Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
6.40
+0.05 (0.79%)
At close: Aug 13, 2025, 4:00 PM
6.16
-0.24 (-3.75%)
Pre-market: Aug 14, 2025, 9:15 AM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $341.27 million as of August 14, 2025. Its market cap has increased by 85.88% in one year.
Market Cap
341.27M
Enterprise Value
260.02M
1-Year Change
85.88%
Ranking
Category
Stock Price
$6.40
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $341.27M, an increase of 53.46%. That is a compound annual growth rate of 11.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 341.27M | -7.44% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |